Researchers hope a new treatment developed in the United Kingdom will prove vital in controlling future flu pandemics such as H1N1 (swine) flu, bird flu as well as ending the need for annual flu jabs. Developed by scientists at Oxford University, the new vaccine works by targeting protein cells inside the influenza A virus, instead of current vaccines that attack proteins on the outside of the flu virus.